Abstract: A linear motor achieves both a decrease in pulsation and an increase in propulsion with a 6n teeth structure provided with: a first mover for holding permanent magnets arranged longitudinally; a first stator having 6n teeth that are arranged so as to oppose the first mover and 6n windings that are wound on the respective teeth; a second mover holding permanent magnets longitudinally; a second stator having 6n teeth that are arranged in the longitudinal direction so as to oppose the second mover and 6n windings that are wound on the respective teeth The permanent magnets opposing each other in the first mover and the second mover are disposed with a phase difference of ?/2 in the moving direction of the two movers, and electrical currents with a phase difference of (1+6m)?/3 or (2+6m)?/3 are supplied to the windings opposing each other in the first stator and the second stator.

Abstract: Proposed is an acoustic output device that obtains enough distance attenuation to achieve localization of a sound field by controlling the driving of a loudspeaker array by use of a more compact shape. The acoustic output device 10 comprises: a loudspeaker array 20 that includes a plurality of loudspeakers 20-1, 20-2, . . . , 20-N arranged in a two-dimensional plane; and an amplifier array 40 that includes a plurality of amplifiers 40-1, 40-2, . . . , 40-N that control the amplitude and phase of the drive signals for each loudspeaker according to the eigenvectors of the predetermined radiation mode of the loudspeaker array 20.

Abstract: A laser processing system is equipped with a processing laser beam irradiation device configured to irradiate a processing object with processing laser beam and perform ablation processing. The laser processing system is configured to obtain an ablation image of a processed portion of the processing object based on scattered light from the processed portion during processing of the processing object with the processing laser beam and to estimate an ablation volume by applying a learning result obtained by deep learning of a relationship between the ablation image and the ablation volume to the obtained ablation image.

Abstract: In a method for designing a mirror, a design formula of a reflecting surface is used which is derived based on conditions that: an intersection point between a sagittal light source ray and an incoming light ray to an MA point and an intersection point between a meridional light source ray and the incoming light ray to the MA point are represented by using L1sA and L1mA, respectively; an intersection point between an outgoing light ray from the MA point and a sagittal virtual collected light ray and an intersection point between the outgoing light ray from the MA point and a meridional virtual collected light ray are expressed by using L2sA and L2mA; an intersection point between a sagittal virtual light source ray and an incoming light ray to an MB point and an intersection point between a meridional virtual light source ray and the incoming light ray to the MB point are expressed by using L2sA and L2mA, and L; and an intersection point between an outgoing light ray from the MB point and the sagittal collect

Abstract: An ammonia manufacturing apparatus of an embodiment includes: an electrochemical reaction cell including: a first reaction tank in which a reduction electrode is arranged and gaseous nitrogen is supplied; a second reaction tank in which an oxidation electrode is arranged and an electrolytic solution containing water or water vapor is supplied; and a diaphragm provided between the first reaction tank and the second reaction tank. In the ammonia manufacturing apparatus of the embodiment, the reduction electrode includes a reduction catalyst that reduces nitrogen to produce ammonia, a porous carbon material that supports the reduction catalyst, and an organic polymer material that binds the porous carbon material. The porous carbon material has pores with a BET average pore size of 1 nm or more and 15 nm or less.

Abstract: The purpose of the present invention is to provide, for translation in a cell-free translation system, a novel translation system capable of synthesizing a peptide having therein consecutive non-proteinogenic amino acids. The present invention provides a tRNA containing the base sequence represented by SEQ ID NO: 1 and encoding a non-proteinogenic amino acid.

Abstract: An extracellular potential measurement device includes multiple insulating films each of which is made from an electric insulating material, the insulating films being stacked and bonded to each other; and multiple electrode wires each of which is made from an electroconductive material, the electrode wires being arranged in multiple heights. Each of the electrode wires is interposed between an upper insulating film and a lower insulating film. Each of the insulating films, except for a lowermost insulating film, has an opening penetrating the insulating film. The opening in a lower insulating film has a size that is less than that of the opening in an upper insulating film, the openings in the insulating films being overlapped to form a recess having a size reducing downward, the recess being adapted to store a collection of cells. Each of the electrode wires has an end that is located near an opening in an insulating film that is immediately below the electrode wire, the ends being exposed in the recess.

Abstract: A joined article including: a resin (1) having a linear expansion coefficient at 30° C. to 200° C. of 17 ppm/° C. or higher and a thickness of 5 to 100 ?m; and a metal joined to a surface of the resin (1) and having a thickness of 5 to 50 ?m. The resin (1) includes a heat-affected layer that is close to the metal and that occupies 80% or less of the thickness of the resin (1), and the joined article is a dielectric material for a substrate. Also disclosed is a substrate including the joined article and a resin (2) stacked on the joined article.

Abstract: Provided are vitamin D3 derivatives of formula (I), pharmaceutical compositions thereof, and pharmaceutical or medical uses thereof for treating metabolic disease, a liver disease, obesity, diabetes, cardiovascular disease, or cancer in a patient in need thereof.

Abstract: An image processing device includes a determination unit configured to determine a type of autophagy induced in a cell, based on information indicative of autophagic activity in the cell present in a cell image in which the cell is image captured and based on information indicative of congestion of molecules in the cell present in the cell image.

Abstract: In one embodiment, the present disclosure provides pharmaceutical compositions for suppressing the progression of fibrosis in systemic sclerosis, which contain an antibody against IL-31 receptor A as an active ingredient. In another embodiment, the present disclosure provides pharmaceutical compositions for suppressing Th2 polarization to suppress the progression of fibrosis in systemic sclerosis, which comprise an antibody against IL-31 receptor A as an active ingredient. In a certain embodiment, the above-mentioned antibody is an antibody having a neutralizing activity against IL-31 receptor A.

Abstract: An object is to prevent eavesdropping in quantum key distribution. A photon detector outputs an output current indicating a result of detecting a quantum signal. A current-voltage conversion unit converts the output current into an output voltage signal. An analog-to-digital converter outputs an output voltage signal obtained by analog-digital conversion of the output voltage signal. A signal processing unit performs predetermined signal processing on the output voltage signal, and outputs a photon detection signal indicating a result of detecting the quantum signal. When a time difference between a timing at which the quantum signal is incident into the photon detector and a reference timing determined based on a clock signal is not within a determination range, the photon detection signal is not output from the signal processing unit.

Abstract: Disclosed are a novel therapeutic means effective and practical against cancer, and a novel substance useful as such a therapeutic means. Provided are novel peptides derived from a partial region of HMGN1, HMGN2, HMGN4 or HMGN5, and anti-cancer agents and anti-cancer effect enhancers containing the peptide as an active ingredient. The peptide of the present invention has an anti-tumor effect even independently, and exerts a remarkably excellent anti-tumor effect particularly when used in combination with an immune checkpoint regulator, or an anti-CD4 antibody or antigen-binding fragment thereof.

Abstract: In a method for designing a mirror when any point on a reflecting surface is represented by M, coordinates of an intersection point between a sagittal light source ray and an incoming light ray to the M point and an intersection point between a meridional light source ray and the incoming light ray to the M point are expressed by using L1s and L1m, and coordinates of an intersection point between an outgoing light ray from the M point and a sagittal collected light ray and an intersection point between the outgoing light ray from the M point and a meridional collected light ray are expressed by using L2s and L2m. A mirror is designed using design formulas of a reflecting surface derived based on the coordinates and a condition that an optical path length from a light source position to a light collection position is constant with respect to any point on the reflecting surface for both the light collection in the sagittal direction and the light collection in the meridional direction.

Abstract: An olefin production device for producing an olefin from a raw material gas containing methane and oxygen includes a reactor containing: a first catalyst; and a second catalyst disposed downstream of the first catalyst in a flow direction of the raw material gas. The first catalyst is a catalyst in which a zirconium salt or carbonate of an alkali metal, an oxide of an alkaline earth metal, an oxide of one kind of lanthanoid element, a composite oxide containing a lanthanoid element, or a combination thereof is supported on a support. The second catalyst is a catalyst containing a tungsten oxide, phosphate, or carbonate of an alkali metal.

Abstract: An electromagnetic wave detecting device comprising: an emission unit configured to emit electromagnetic waves having coherence; an electromagnetic wave modulating unit configured to modulate one or both of a phase and an amplitude of the emitted electromagnetic waves and to change a state of the modulation relative to an imaging target; and a post-modulation electromagnetic wave intensity detecting unit configured to detect an intensity of post-modulation electromagnetic waves, which are the modulated electromagnetic waves acquired by modulating the electromagnetic waves emitted from the emission unit using the imaging target and the electromagnetic wave modulating unit, using one pixel.

Abstract: A challenge is to provide an art to identify mice as individuals from captured images of one or more mice that are doing activity in a predetermined activity range. An image processing device includes an image acquisition unit, a part extraction unit, and an individual identification unit. The image acquisition unit acquires a captured video of a state in which one or more animals are doing activity in a predetermined activity range. An outline detection unit extracts the outlines of the bodies of the one or more animals from each of multiple unit images included in the video. The individual identification unit analyzes the multiple outlines detected from each of the multiple unit images by the outline detection unit, in a time-series manner and identifies the one or more animals as individuals in each of the unit images on the basis of the analysis results. Thus, the challenge is solved.

Abstract: A method for producing a ligated DNA formed by ligating DNA fragments is disclosed. The method includes (a1) preparing (1) a first vector containing structure 5?-R1-D(i)-R2-M1-R2?-D(ii)-R1?-3? and (2) a second vector containing structure 5?-R1-D(iii)-R2-M2-R2?-D(iv)-R1?-3?, which each contain recognition sequences of restriction enzymes R1, R1?, R2, and R2; selectable marker genes M1 and M2 different from each other; and DNA fragments for ligation D(i) to D(iv); (b1) treating the first vector with first restriction enzyme and second restriction enzyme to obtain a first vector fragment composed of structure 5?-D(i)-R2-M1-R2?-D(ii)-3; (c1) treating the second vector with third restriction enzyme and fourth restriction enzyme to obtain a second vector fragment with removed structure 5?-R2-M2-R2?-3?; and (d1) ligating the first vector fragment obtained in b1 and the second vector fragment obtained in cl by a ligation reaction to generate a third vector containing structure (3) 5?-R1-D(i)1-R2-M1-R2?-D(ii)1-R1?-3?.

Abstract: The present invention provides an antibody recognizing a v9 fragment of the cell adhesion molecule CADM1.

Abstract: A method of producing a resin modifier, the method comprising a process of polymerizing an ethylene unsaturated monomer in the presence of a cellulose nanofiber, the cellulose nanofiber being reacted with an amine or a quaternary ammonium salt compound.